مراجَع تحريريًا · sa-kfshrc-clinical-pgx

KFSHRC Clinical Pharmacogenomics Program

السعوديةHuman health and population genomicsActive / operational

Integrates germline pharmacogenetic testing and clinical decision support into prescribing across multiple specialties.

01 / نظرة عامة على المشروع

ما الذي يثبته السجل.

النطاق الجغرافي: KFSHRC patients, initially cardiology and neurology and later transplant and other specialties
نوع المشروع: Clinical precision-prescribing implementation program
مجال البحث: Pharmacogenomics
السنوات: 2023–
حالة المشروع: active
أساس تحديد الحالة: Launched in September/October 2023; KFSHRC reported more than 1,500 patients analyzed and continued specialty expansion in October 2024.
تاريخ دليل الحالة: 2024-10-01
الحجم: More than 1,500 patients by October 2024; over 70% carried altered function in at least three genes. Initial phase covered six medicines and later expanded.

02 / المؤسسات والمجتمع

الجهات القائدة: King Faisal Specialist Hospital & Research Centre (KFSHRC)
الجهات الشريكة: غير مذكور
الكائن / المجتمع: Saudi and national-referral KFSHRC patients receiving genotype-guided medicines

03 / البيانات والإتاحة

Clinical service; individual data controlled

لا يوجد رقم وصول أو معرّف عام مدرج لهذا السجل.

04 / الدليل والمصدر

Operational clinical-genomics implementation program with an explicit patient scale and prescribing integration.

Distinct from the SHGP population-frequency pharmacogenomics cohort; included under KFSHRC's broader Genomic Medicine Center umbrella.

الإصدار v0.2.0